EMErik Munson

Erik Munson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erik Munson has a total of 178 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Valid and included novel bacterial taxa isolated from aquatic host species described in 2024–2025

    by Tryssa E. de Ruyter, Claire R. Burbick, Sara D. Lawhon, Trinity Krueger, Lul Javier, Erik Munson

    The description of new taxa and nomenclature updates to currently known taxa from aquatic animal species continues at a rapid pace. After a review of the literature from 2024 to 2025, bacteria in major morphologic categories were compiled. As previously noted, bacteria characterized as oxidase-positive Gram-negative bacilli predominated. Additions included new taxa in common families associated with aquatic environments like Aeromonadaceae , Flavobacteriaceae , and Pseudomonadaceae , as well as more uncommon families, such as Pasteurellaceae . A number of Gram-positive organisms are noted, including Planococcus notacanthi sp. nov., the sole coccus described, and multiple bacilli, including new taxa in the Streptomyces and Paenibacillus genera. Two anaerobic species are highlighted, as well as a spirochete and a new member of family Chlamydiaceae . Revised taxa are briefly mentioned. As in previous reviews, most new and revised taxa are isolated from healthy aquatic animals, and the role of these new bacteria in health and disease has yet to be elucidated. Bacteria with potential clinical significance for aquatic animals or potential production of bioactive or antimicrobial substances are highlighted.

  • Open Access

    An update on novel and included taxa and revised taxonomic status of bacteria isolated from non-domestic animals described in 2025

    by Hayley Masterson, Claire R. Burbick, Sara D. Lawhon, Lionel Carapia, Erik Munson

    Maintaining an updated list of and analyzing new and revised microbial taxa originating from non-domestic animal species are considered important annual endeavors. As researchers continue to investigate complex microbiota in animal and environmental samples, it is critical that findings are accessible to all with an interest in wildlife animal species. Herein, data concerning novel bacterial taxa and taxonomic revisions of bacteria derived from non-domestic wildlife specimens that were published in peer-reviewed literature and/or accepted during 2025 are summarized and analyzed. While few of the newly identified or accepted bacteria are associated with clinical disease in the host of origin, some are closely related to bacteria that have been implicated in disease or opportunistic infections. Others may contribute valuable information toward future research involving probiotics, antimicrobial resistance, metabolic health, detoxification, and the degradation of toxic materials. Notable bacteria include Helicobacter cappadocius sp. nov., the first species of psychrotrophic Helicobacter , and Limosilactobacillus allomucosae sp. nov., which has potential for use as a probiotic in domestic pigs.

  • Open Access

    An update on novel and included taxa and revised taxonomic status of bacteria isolated from domestic companion and agricultural animals

    by Sara D. Lawhon, Claire R. Burbick, Trinity Krueger, Erik Munson

    The recognition of novel bacteria continues to expand with the decreased cost and rapid adoption of whole genome sequencing for bacteria. A review of newly identified bacterial species and revisions to bacterial nomenclature from 2025 was performed. New members of families Staphylococcaceae , Streptococcaceae , Actinomycetaceae , Pseudomonadaceae , and Pasteurellaceae were recognized in 2025. While most novel organisms identified in 2025 were isolated from normal microbiota of the skin or gastrointestinal tract of healthy animals, there were some notable new taxa, including Macrococcus psychrotolerans sp. nov., which carries a mecB determinant from Staphylococcus aureus . In addition, Buchananella felis sp. nov., isolated from cases of feline pyothorax, becomes the second member of the genus Buchananella , alongside Buchananella hordeovulneris . Within the gram-negative organisms, a new Pseudomonas species and a novel member of Pasteurellaceae , namely, Rodentibacter abscessus sp. nov. isolated from abscesses in pet hamsters, was recognized. Additions to spiral or curved bacteria included Campylobacter canis sp. nov. and Helicobacter gastrocanis sp. nov. Proposed revisions to seven bacterial taxa are briefly described.

  • Open Access

    Update on novel, validly published, and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2025

    by Arianna Carella, Karen C. Carroll, Erik Munson

    This review summarizes novel taxon designations ascribed to prokaryotes derived from human primary clinical material during calendar year 2025, as well as proposed revisions to existing taxonomy. Major activity took place in the Streptococcus genus, as more than one dozen novel species were validly and effectively published, with two of these later classified as synonyms of Streptococcus thalassemiae . Moreover, whole genome sequencing and phylogenetic investigation of Streptococcus mitis group organisms resulted in a proposal to designate five species-level Streptococcus spp. taxa as Streptococcus mitis and an additional taxon as Streptococcus oralis subsp. dentisani . More than one dozen taxa were newly included in order Enterobacterales in 2025. Select novel taxa within genera Providencia and Enterobacter commonly possessed genotypes that conferred resistance to carbapenem and/or higher-generation cephem agents. Stenotrophomonas muris sp. nov. and Terrisporobacter muris sp. nov., initially characterized in gnotobiotic murine systems within the past 4 years, had clinical significance in human infection that was demonstrated in primary literature. The vast majority of the more than 70 novel obligate anaerobic taxa were derived from microbiome studies and had little ascribed clinical significance. Four novel obligate anaerobic Gram-negative taxa were shown to be of greater abundance in persons with Parkinson’s disease than in those without. Updates to taxa previously published in the Journal of Clinical Microbiology compendia reveal that several could serve as reservoirs for multiple antimicrobial resistance determinants. One example is the non-glucose fermentative Gram-negative bacillus Pseudomonas juntendi .

  • Open Access

    Biographical Feature: Joseph E. McDade, PhD

    by Erik Munson

    “At this initial stage of the investigation, the agent…has been distinguished by the following properties: the characteristic disease that it produces in guinea pigs; the characteristic death pattern of chick embryos after yolk-sac inoculation; morphology of the organism in smears of infected yolk sacs and guinea-pig peritoneal exudates; gram-negative characteristics; failure to grow on ordinary bacteriologic media, such as trypticase soy agar, blood agar, and thioglycollate broth; and specific immunofluorescent staining with convalescent-phase serums of patients with … disease. As mentioned above, the organism has since been cultivated on supplemented Mueller-Hinton medium, and studies of its classification are in progress (1). We cannot say as yet whether the organism has previously been isolated from other sources, but it seems clear that this is the first demonstration of its role in human disease. The properties listed above differentiate it from other known microbes causing human disease” (2).

  • Mycoplasma genitalium infection and adverse perinatal outcomes

    by Irene A. Stafford, Erik Munson, Sahana Kodali, Mason Collie, Han-Yang Chen, Damon Getman, Sean C. Blackwell

  • Open Access

    2026 American Society for Microbiology Awards and Prize Program: honorees from clinical microbiology

    by Erik Munson

    In September 2025, the American Society for Microbiology (ASM) announced recipients of honors in the context of the ASM Awards and Prize Program for calendar year 2026. A total of 17 awards, cast across multiple disciplines of the microbial sciences, as well as the ASM Microbiome Data Prize, have collectively been awarded on an annual basis since 2024—with a history of the Awards program dating back to 1968 (ASM Carski Award for Undergraduate Education). The American Academy of Microbiology (AAM), an honorific leadership group and scientific expert panel within ASM, administers this program that highlights outstanding research and/or contributions at every career level and subdiscipline of the microbial sciences. A complete listing of Award honorees for 2026 can be found with the following link: https://asm.org/press-releases/2025/september/asm-announces-honorees-for-2026-awards-and-prize-p.

  • Open Access

    Valid and accepted novel bacterial taxa isolated from domestic companion and agricultural animals described in 2024

    by Sara D. Lawhon, Claire R. Burbick, Trinity Krueger, Elena Ruiz-Reyes, Ayden Wisney-Leonard, Mallory Lenmark, Erik Munson

    Recognizing and updating bacterial names is key to communication between the veterinary clinical microbiology laboratory, veterinarians, and clients. Moraxella oculi sp. nov., distinct from Moraxella bovis and Moraxella bovoculi , was isolated from a cow with infectious bovine keratoconjunctivitis. Several respiratory pathogens were recognized, including Neisseria leonii sp. nov. described from rabbits, Mannheimia indoligenes sp. nov. described from cattle in Europe, and Moraxella haemolytica sp. nov. described from a goat in China. Stenotrophomonas forensis sp. nov. is a novel designation within the Stenotrophomonas maltophilia complex associated with isolates derived from horses. New additions to the Campylobacter genus included Campylobacter californiensis sp. nov. , recovered from bovine feces during a raw milk-associated outbreak of campylobacteriosis in humans. Taxonomic revisions were most notable in Gram-positive organisms. A species within genus Jeotgalicoccus has been renamed, and the subspecies designation Kocuria rosea subsp. polaris comb. nov. has been created. Streptococcus suis was revised to Streptococcus suis subsp. suis subsp. nov. in recognition of the initial description of Streptococcus suis subsp. hashimotonensis subsp. nov., which was isolated from people in Japan with bite wounds from boars. Chlamydophila caviae , which causes respiratory disease and abortion in guinea pigs and is zoonotic, has been revised to Chlamydia caviae comb. nov.


  • Open Access

    Update on novel, validly published, and included bacterial taxa derived from nondomestic animals and taxonomic revisions published in 2024

    by Claire R. Burbick, Sara D. Lawhon, Trinity Krueger, Elena Ruiz-Reyes, Mallory Lenmark, Ayden Wisney-Leonard, Erik Munson

    Description of new and revised taxa originating from non-domestic animal species continues to be pursued. The majority are bacteria isolated from the alimentary system of a variety of healthy wildlife, adding to our understanding of microbial flora present in the normal state. A few new and revised taxa are associated with disease, including a novel Erysipelothrix species associated with sepsis in albatross and a revised species, Allocoenonia anatina comb. nov., associated with Riemerella anatipestifera -like disease in ducks and geese. Representative bacteria from genera that are additionally under study for the remediation of pollutants and bacteria that are related to significant animal or zoonotic pathogens are additionally discussed.